How strong is the link between early antibiotics and later disease?
The association is consistent but modest. Across multiple large studies, children exposed to antibiotics in the first year of life have a 10–50% higher risk of developing conditions like atopic dermatitis (eczema), asthma, obesity, and inflammatory bowel disease (IBD). For example, a nationwide Swedish study of over 720,000 children found that antibiotic exposure in the first year increased the risk of atopic dermatitis by 52% (adjusted hazard ratio 1.52) [3]. A Danish study of nearly 1 million children found a 40% increased risk of Crohn's disease after antibiotic use in the first year [4]. For obesity, a Finnish study of 33,000 children reported a 9% higher risk of overweight and a 20% higher risk of obesity after antibiotic exposure in the first two years [5]. These numbers show a real effect, but they also mean that the vast majority of children who take antibiotics do not develop these conditions.
Is it cause or just confusion? The sibling-control clue
A key question is whether antibiotics directly cause disease or whether the underlying infection (or shared family genetics) is the real culprit. The strongest evidence for a causal role comes from studies that compare siblings—children who share the same family environment and genetics but differ in antibiotic exposure. The Swedish study on atopic dermatitis found that when comparing siblings, the risk dropped from 52% to 24%, meaning about half of the apparent effect was due to shared family factors (like genetics or parental health), but a significant portion remained [3]. Similarly, a meta-analysis of autism and ADHD found that the initial link with antibiotics disappeared entirely when sibling-matched studies were pooled, suggesting that for neurodevelopmental conditions, the association may be entirely due to confounding [1]. This pattern—stronger associations in general population studies, weaker in sibling comparisons—indicates that antibiotics are a partial cause, not just a marker, but the effect is smaller than initial numbers suggest.
How could antibiotics cause disease? The gut microbiome link
The most plausible mechanism is that antibiotics disrupt the developing gut microbiome, which in turn alters immune system and metabolic development. A birth cohort study of 2,140 children found that antibiotic exposure in the first year was linked to higher rates of overweight and obesity at age 2.5, and this was accompanied by specific changes in gut bacteria—higher levels of Faecalibacterium, Agathobacter, and Klebsiella, and lower levels of Bifidobacterium [2]. Animal experiments confirm this: mice given antibiotics early in life developed worse allergic airway inflammation and colitis, and these effects were linked to gut microbiome disruption and abnormal lipid metabolism [6][7]. The timing matters—the first two years of life appear to be a critical window, as antibiotic exposure during pregnancy or the perinatal period showed no association with obesity in one large study [5]. This suggests that the microbiome is most vulnerable in early infancy, and antibiotics during this window can have lasting effects on immune and metabolic programming.
About These Sources
This answer is built on 7 peer-reviewed studies — published from 2021 to 2026, 3 from 2024 or later, 4 in Q1 journals, collectively cited 139 times — selected as the most relevant from 15 studies that passed quality screening, drawn from 60 papers retrieved from a database of over 500 million.
Sources used in this answer
Early Life Antibiotic Exposure and the Subsequent Risk of Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder: A Systematic Review and Meta-Analysis
A systematic review and meta-analysis found that early-life antibiotic exposure was associated with increased risk of autism (OR 1.13) and ADHD (OR 1.18), but these associations disappeared in sibling-matched studies, suggesting confounding by genetic and familial factors.
Early-life antibiotic exposure increases the risk of childhood overweight and obesity in relation to dysbiosis of gut microbiota: a birth cohort study
In a birth cohort of 2,140 children, antibiotic exposure in the first year was associated with higher rates of overweight and obesity at age 2.5, and with specific gut microbiome changes (higher Faecalibacterium, Agathobacter, Klebsiella; lower Bifidobacterium).
Association of Early Life Exposure to Antibiotics With Risk of Atopic Dermatitis in Sweden
In a Swedish nationwide cohort of 722,767 children, prenatal antibiotics were associated with a 10% increased risk of atopic dermatitis, but this disappeared in sibling analysis; infant antibiotics were associated with a 52% increased risk, which attenuated to 24% in sibling analysis, indicating partial confounding by familial factors.
Early-Life Exposure to Antibiotics and Risk for Crohn’s Disease: A Nationwide Danish Birth Cohort Study
In a Danish birth cohort of 979,039 children, antibiotic use in the first year was associated with a 40% increased risk of Crohn's disease (aHR 1.4), with a much higher risk (4.1-fold) for ≥6 courses; absolute risk remained very low (0.16‰ vs 0.11‰ by age 11).
Early-life antibiotic exposure and the risk of overweight and obesity in children
In a Finnish cohort of 33,095 children, antibiotic exposure in the first two years of life was associated with a 9% higher risk of overweight and 20% higher risk of obesity; no association was found for antibiotic exposure before or at birth.
Protective effect and mechanism of <i>Lacticaseibacillus paracasei</i> 207-27 administration on colitis in antibiotic-exposed mice in early life
In a mouse model, early-life antibiotic exposure worsened colitis, and administration of Lacticaseibacillus paracasei 207-27 improved gut microbiota composition, reduced inflammation, and protected intestinal barrier function.
Early-life antibiotic exposure promotes house dust mite-induced allergic airway inflammation by impacting gut microbiota and lung lipid metabolism
In a mouse model, early-life antibiotic exposure (cefixime, azithromycin, cefuroxime) promoted different types of allergic airway inflammation to house dust mite, linked to gut microbiota disruption and abnormal lung lipid metabolism.
